In conclusion, this comprehensive bioinformatic analysis revealed that SNAI2 and EMT-related lncRNAs could be reliable biomarkers for diagnosing CAD and may be used for decision-making in the treatment of CAD patients. The gene discussed is SNAI2; the disease is coronary artery disorder.